<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00831220</url>
  </required_header>
  <id_info>
    <org_study_id>PI04/1946</org_study_id>
    <nct_id>NCT00831220</nct_id>
  </id_info>
  <brief_title>Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Son Dureta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondo de Investigacion Sanitaria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Son Dureta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To investigate the potential role of endothelial dysfunction as a pathogenic
      mechanism of cardiovascular events in COPD. Hypothesis: endothelial function is abnormal in
      patients with COPD, particularly during exacerbations of the disease. Design: prospective and
      controlled study performed in an university hospital. Population: we compare 4 groups of
      subjects, 44 patients with stable COPD, 35 patients with acute exacerbation of COPD, 10
      smokers or former smokers with normal lung function and 10 never smokers matched by physical
      activity and BMI. Study variables: a) clinical variables: clinical information, physical
      examination, pulmonary function tests, ECG and sputum culture; b) Biological variables:
      number of Circulating Endothelial Progenitor Cells, vascular growth factors (vascular
      endothelial growht factor and erythropoietin), systemic inflammation (C-reactive protein,
      white blood cells), peripheral venous blood test (including hemogram, biochemical analysis
      with glycemia, cholesterol, LDLcol, HDLcol); and c) systemic vascular reactivity assessment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">99</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients with a COPD exacerbation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Patients with stable COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Smokers or former smokers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Never smokers</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an exacerbation of COPD admitted to our hospital, stable COPD recruited in an
        ambulatory basis, smokers or former smokers and never smokers recruited in our laboratory.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with moderate to very severe COPD admitted in the hospital because of an
             exacerbation, and,

          -  Patients with moderate to very severe COPD in stable condition.

        Exclusion Criteria:

          -  Patients with an exacerbation of COPD who needed invasive or non invasive mechanical
             ventilation

          -  Patients with other chronic inflammatory diseases.

          -  Patients with other acute or active chronic systemic disease such as heart failure,
             renal insufficiency, etc.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ernest Sala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Servei de Pneumologia, Hospital Universitari Son Dureta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitari Son Dureta</name>
      <address>
        <city>Palma Mallorca</city>
        <state>Illes Balears</state>
        <zip>07014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2009</study_first_submitted>
  <study_first_submitted_qc>January 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2009</study_first_posted>
  <last_update_submitted>January 27, 2009</last_update_submitted>
  <last_update_submitted_qc>January 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Ernest Sala</name_title>
    <organization>Servei de Pneumologia, Hospital Universitari Son Dureta</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>exacerbations</keyword>
  <keyword>EPCs</keyword>
  <keyword>Erythropoietin</keyword>
  <keyword>C-RP</keyword>
  <keyword>COPD and endothelial dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

